Food and Drug Administration
federal agency
Funding opportunities
Retail Food Safety Regulatory Association Collaboration
The purpose of this NOFO is to collaboratively advance retail food initiatives to reduce foodborne illness. This funding opportunity aims to advance practices i...
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication...
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Ant...
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development...
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing state animal food...
Laboratory Flexible Funding Model (LFFM)
This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal food testing laboratories in support of an integrated...
Animal and Veterinary Innovation Centers (U18)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are inten...
Minor Use Minor Species Development of Drugs (R01)
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Proje...
Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectiv...
Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases
CBER seeks to support the application of novel technologies for advanced manufacturing of complex biologic products, and innovative analytical approaches to imp...
AAV Vector manufacturing for diseases affecting very small populations
CBER seeks to advance the development of gene therapies for diseases affecting very small populations, potentially even single individuals, by enhancing innovat...
Minor Use Minor Species Development of Drugs (R01) Clinical Trials Not Allowed
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Proje...
Drug Development Tools Research Grants (U01 Clinical Trial Optional)
The drug development tool programs at FDA are created to assist the applicants to successfully complete the qualification process, and to make the qualified too...
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning
For generic drug development, population pharmacokinetics (popPK) analysis is a critical part of the emerging technology of model-based bioequivalence (BE) anal...
Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes.
In 2018, OPSA launched an effort to develop of a quantitative system-dynamic model of the opioid crisis to help FDA a) understanding the complexity of the inter...
Dermal Physiologically-Based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-Solvent Following the Application of Generic Dermatological Products
The overall objective of this funding opportunity is to develop an enhanced mechanistic PBPK model for generic dermatological drug products by accounting for th...
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans
The purpose of this funding opportunity is to systematically quantify the protein levels of potential metabolizing enzymes and transporters in rabbit eye and hu...
Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD)
Impulse oscillometry (IOS) is a technique used to assess lung function that does not require patient coordination, that uses sound waves that are introduced to...
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership
Millions of children receive anesthetic and sedation drugs each year for surgical and non-surgical procedures. Over the past two decades, an expanding body of d...
Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)
ACTTION public-private partnership (PPP) is a multi-year, multi-phase initiative that is aligned with the FDA's Critical Path Initiative. This ppp has been desi...
Advance conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS)
The purpose of this FOA is to assist Territorial (SLTT) retail food regulatory programs with achieving conformance with the Voluntary National Retail Food Regul...
Manufactured Food Regulatory Program Alliance
1. Assist FDA in meeting provisions of the FDA Food Safety Modernization Act;2. Support the efforts of local government agencies to build an Integrated National...
CFD Models to aid the development of generic inhalation products
Current US Food and Drug Administration product specific guidance (PSG) bioequivalence (BE) recommendations for orally inhaled drug products such as metered dos...
Implementation of the National Evaluation System for Health Technology (NEST) Coordinating Center (CC)
The purpose of this announcement is to continue to support the implementation of NEST through operations of the NEST CC toward sustainable operations to coincid...
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability
The purpose of the research is to develop methods for evaluating the impact of small design differences in the user interface of generic drug-device combination...